Federal Register / Vol. 61, No. 108 / Tuesday, June 4, 1996 / Notices 28225

Time: 8:00 a.m.

Place: Doubletree Hotel, Rockville,

MD.

Contact Person: Dr. Bill Bunnag,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5212, Bethesda,

Maryland 20892, (301) 435–1177.

Name of SEP: Multidisciplinary

Sciences.

Date: July 8–10, 1996.

Time: 8:00 a.m.

Place: Ramada Inn, Rockville, MD.

Contact Person: Dr. Dharam Dhindsa,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5206, Bethesda,

Maryland 20892, (301) 435–1174.

Name of SEP: Biological and

Physiological Sciences.

Date: July 8, 1996.

Time: 8:00 a.m

Place: Doubletree Hotel, Rockville,

MD.

Contact Person: Dr. Harish Chopra,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5112, Bethesda,

Maryland 20892, (301) 435–1169.

Name of SEP: Multidisciplinary

Sciences.

Date: July 10, 1996.

Time: 8:00 a.m.

Place: Doubletree Hotel, Rockville,

MD.

Contact Person: Dr. Bill Bunnag,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5212, Bethesda,

Maryland 20892, (301) 435–1177.

Name of SEP: Biological and

Physiological Sciences.

Date: August 1, 1996.

Time: 8:30 a.m.

Place: Doubletree Hotel, Rockville,

MD.

Contact Person: Dr. Abubakar Shaikh,

Scientific Review Administrator, 6701

Rockledge Drive, Room 6166, Bethesda,

Maryland 20892, (301) 435–1042.

The meetings will be closed in

accordance with the provisions set forth

in secs. 552b(c)(4) and 552b(c)(6), Title

5, U.S.C. Applications and/or proposals

and the discussions could reveal

confidential trade secrets or commercial

property such as patentable material

and personal information concerning

individuals associated with the

applications and/or proposals, the

disclosure of which would constitute a

clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Program Nos. 93.306, 93.333, 93.337, 93.393–

93.396, 93.837–93.844, 93.846–93.878,

93.892, 93.893, National Institutes of Health,

HHS)

Dated: May 29, 1996.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 96–13958 Filed 6–3–96; 8:45 am]

BILLING CODE 41140–01–M

Substance Abuse and Mental Health

Services Administration

Current List of Laboratories Which

Meet Minimum Standards To Engage in

Urine Drug Testing for Federal

Agencies, and Laboratories That Have

Withdrawn From the Program

AGENCY: Substance Abuse and Mental

Health Services Administration, HHS

(Formerly: National Institute on Drug

Abuse, ADAMHA, HHS).

ACTION: Notice.

SUMMARY: The Department of Health and

Human Services notifies Federal

agencies of the laboratories currently

certified to meet standards of Subpart C

of Mandatory Guidelines for Federal

Workplace Drug Testing Programs (59

FR 29916, 29925). A similar notice

listing all currently certified laboratories

will be published during the first week

of each month, and updated to include

laboratories which subsequently apply

for and complete the certification

process. If any listed laboratory’s

certification is totally suspended or

revoked, the laboratory will be omitted

from updated lists until such time as it

is restored to full certification under the

Guidelines.

If any laboratory has withdrawn from

the National Laboratory Certification

Program during the past month, it will

be identified as such at the end of the

current list of certified laboratories, and

will be omitted from the monthly listing

thereafter.

FOR FURTHER INFORMATION CONTACT: Mrs.

Giselle Hersh, Division of Workplace

Programs, Room 13A–54, 5600 Fishers

Lane, Rockville, Maryland 20857; Tel.:

(301) 443–6014.

SUPPLEMENTARY INFORMATION:

Mandatory Guidelines for Federal

Workplace Drug Testing were developed

in accordance with Executive Order

12564 and section 503 of Pub. L. 100–

71. Subpart C of the Guidelines,

‘‘Certification of Laboratories Engaged

in Urine Drug Testing for Federal

Agencies,’’ sets strict standards which

laboratories must meet in order to

conduct urine drug testing for Federal

agencies. To become certified an

applicant laboratory must undergo three

rounds of performance testing plus an

on-site inspection. To maintain that

certification a laboratory must

participate in a quarterly performance

testing program plus periodic, on-site

inspections.

Laboratories which claim to be in the

applicant stage of certification are not to

be considered as meeting the minimum

requirements expressed in the HHS

Guidelines. A laboratory must have its

letter of certification from SAMHSA,

HHS (formerly: HHS/NIDA) which

attests that it has met minimum

standards.

In accordance with Subpart C of the

Guidelines, the following laboratories

meet the minimum standards set forth

in the Guidelines:

Aegis Analytical Laboratories, Inc., 624

Grassmere Park Rd., Suite 21, Nashville,

TN 37211, 615–331–5300

Alabama Reference Laboratories, Inc., 543

South Hull St., Montgomery, AL 36103,

800–541–4931/205–263–5745

American Medical Laboratories, Inc., 14225

Newbrook Dr., Chantilly, VA 22021, 703–

802–6900

Associated Pathologists Laboratories, Inc.,

4230 South Burnham Ave., Suite 250, Las

Vegas, NV 89119–5412, 702–733–7866

Associated Regional and University

Pathologists, Inc. (ARUP), 500 Chipeta

Way, Salt Lake City, UT 84108, 801–583–

2787

Baptist Medical Center—Toxicology

Laboratory, 9601 I–630, Exit 7, Little Rock,

AR 72205–7299, 501–227–2783 (formerly:

Forensic Toxicology Laboratory Baptist

Medical Center)

Bayshore Clinical Laboratory, 4555 W.

Schroeder Dr., Brown Deer, WI 53223,

414–355–4444/800–877–7016

Cedars Medical Center, Department of

Pathology, 1400 Northwest 12th Ave.,

Miami, FL 33136, 305–325–5810

Centinela Hospital Airport Toxicology

Laboratory, 9601 S. Sepulveda Blvd., Los

Angeles, CA 90045, 310–215–6020

Clinical Reference Lab, 11850 West 85th St.,

Lenexa, KS 66214, 800–445–6917

CompuChem Laboratories, Inc., 1904

Alexander Drive, Research Triangle Park,

NC 27709, 919–549–8263/800–833–3984

(Formerly: CompuChem Laboratories, Inc.,

A Subsidiary of Roche Biomedical

Laboratory, Roche CompuChem

Laboratories, Inc., A Member of the Roche

Group)

CORNING Clinical Laboratories, 4771 Regent

Blvd., Irving, TX 75063, 800–526–0947

(formerly: Damon Clinical Laboratories,

Damon/MetPath)

CORNING Clinical Laboratories, 875

Greentree Rd., 4 Parkway Ctr., Pittsburgh,

PA 15220–3610, 800–284–7515 (formerly:

Med-Chek Laboratories, Inc., Med-Chek/

Damon, MetPath Laboratories)

CORNING Clinical Laboratories, 24451

Telegraph Rd., Southfield, MI 48034, 800–

444–0106 ext. 650 (formerly: HealthCare/

Preferred Laboratories, HealthCare/

MetPath)

CORNING Clinical Laboratories Inc., 1355

Mittel Blvd., Wood Dale, IL 60191, 708–

595–3888 (formerly: MetPath, Inc.,

CORNING MetPath Clinical Laboratories)

CORNING Clinical Laboratories, South

Central Divison, 2320 Schuetz Rd., St.

Louis, MO 63146, 800–288–7293 (formerly:

Metropolitan Reference Laboratories, Inc.)

CORNING Clinical Laboratory, One Malcolm

Ave., Teterboro, NJ 07608, 201–393–5000

(formerly: MetPath, Inc., CORNING

MetPath Clinical Laboratories)

CORNING National Center for Forensic

Science, 1901 Sulphur Spring Rd.,
28226 Federal Register / Vol. 61, No. 108 / Tuesday, June 4, 1996 / Notices

Baltimore, MD 21227, 410–536–1485

(formerly: Maryland Medical Laboratory,

Inc., National Center for Forensic Science)

CORNING Nichols Institute, 7470–A Mission

Valley Rd., San Diego, CA 92108–4406,

800–446–4728/619–686–3200 (formerly:

Nichols Institute, Nichols Institute

Substance Abuse Testing (NISAT))

Cox Medical Centers, Department of

Toxicology, 1423 North Jefferson Ave.,

Springfield, MO 65802, 800–876–3652/

417–836–3093

Dept. of the Navy, Navy Drug Screening

Laboratory, Great Lakes, IL, Building 38–H,

Great Lakes, IL 60088–5223, 708–688–

2045/708–688–4171

Diagnostic Services Inc., dba DSI, 4048 Evans

Ave., Suite 301, Fort Myers, FL 33901,

813–936–5446/800–735–5416

Doctors Laboratory, Inc., P.O. Box 2658 906

Julia Dr., Valdosta, GA 31604, 912–244–

4468

Drs. Weber, Palmer, Macy, Chartered, 338 N.

Front St., Salina, KS 67401, 913–823–9246

DrugProof, Division of Dynacare/Laboratory

of Pathology, LLC, 1229 Madison St., Suite

500, Nordstrom Medical Tower, Seattle,

WA 98104, 800–898–0180 / 206–386–2672,

(formerly: Laboratory of Pathology of

Seattle, Inc., DrugProof, Division of

Laboratory of Pathology of Seattle, Inc.)

DrugScan, Inc., P.O. Box 2969, 1119 Mearns

Rd., Warminster, PA 18974, 215–674–9310

ElSohly Laboratories, Inc., 5 Industrial Park

Dr., Oxford, MS 38655, 601–236–2609

General Medical Laboratories, 36 South

Brooks St., Madison, WI 53715, 608–267–

6267

Harrison Laboratories, Inc., 9930 W. Highway

80, Midland, TX 79706, 800–725–3784/

915–563–3300 (formerly: Harrison &

Associates Forensic Laboratories)

Jewish Hospital of Cincinnati, Inc., 3200

Burnet Ave., Cincinnati, OH 45229, 513–

569–2051

LabOne, Inc., 8915 Lenexa Dr., Overland

Park, Kansas 66214, 913–888–3927

(formerly: Center for Laboratory Services, a

Division of LabOne, Inc.)

Laboratory Corporation of America, 13900

Park Center Rd., Herndon, VA 22071, 703–

742–3100 (Formerly: National Health

Laboratories Incorporated)

Laboratory Corporation of America, 21903

68th Ave. South, Kent, WA 98032, 206–

395–4000 (Formerly: Regional Toxicology

Services)

Laboratory Corporation of America Holdings,

1120 Stateline Rd., Southaven, MS 38671,

601–342–1286 (Formerly: Roche

Biomedical Laboratories, Inc.)

Laboratory Corporation of America Holdings,

69 First Ave., Raritan, NJ 08869, 800–437–

4986 (Formerly: Roche Biomedical

Laboratories, Inc.)

Laboratory Specialists, Inc., 113 Jarrell Dr.,

Belle Chasse, LA 70037, 504–392–7961

Marshfield Laboratories, 1000 North Oak

Ave., Marshfield, WI 54449, 715–389–

3734/800–222–5835

MedExpress/National Laboratory Center,

4022 Willow Lake Blvd., Memphis, TN

38175, 901–795–1515

Medical College Hospitals Toxicology

Laboratory, Department of Pathology, 3000

Arlington Ave., Toledo, OH 43699–0008,

419–381–5213

Medlab Clinical Testing, Inc., 212 Cherry

Lane, New Castle, DE 19720, 302–655–

5227

MedTox Laboratories, Inc., 402 W. County

Rd. D, St. Paul, MN 55112, 800–832–3244/

612–636–7466

Methodist Hospital of Indiana, Inc.,

Department of Pathology and Laboratory

Medicine, 1701 N. Senate Blvd.,

Indianapolis, IN 46202, 317–929–3587

Methodist Medical Center Toxicology

Laboratory, 221 N.E. Glen Oak Ave.,

Peoria, IL 61636, 800–752–1835/309–671–

5199

MetroLab-Legacy Laboratory Services, 235 N.

Graham St., Portland, OR 97227, 503–413–

4512, 800–237–7808 (x4512)

National Toxicology Laboratories, Inc., 1100

California Ave., Bakersfield, CA 93304,

805–322–4250

Northwest Toxicology, Inc., 1141 E. 3900

South, Salt Lake City, UT 84124, 800–322–

3361

Oregon Medical Laboratories, P.O. Box 972,

722 East 11th Ave., Eugene, OR 97440–

0972, 503–687–2134

Pathology Associates Medical Laboratories,

East 11604 Indiana, Spokane, WA 99206,

509–926–2400

PharmChem Laboratories, Inc., 1505–A

O’Brien Dr., Menlo Park, CA 94025, 415–

328–6200/800–446–5177

PharmChem Laboratories, Inc., Texas

Division, 7606 Pebble Dr., Fort Worth, TX

76118, 817–595–0294 (formerly: Harris

Medical Laboratory)

Physicians Reference Laboratory, 7800 West

110th St., Overland Park, KS 66210, 913–

338–4070/800–821–3627

Poisonlab, Inc., 7272 Clairemont Mesa Rd.,

San Diego, CA 92111, 619–279–2600/800–

882–7272

Premier Analytical Laboratories, 15201 I–10

East, Suite 125, Channelview, TX 77530,

713–457–3784 (formerly: Drug Labs of

Texas)

Presbyterian Laboratory Services, 1851 East

Third Street, Charlotte, NC 28204, 800–

473–6640

Puckett Laboratory, 4200 Mamie St.,

Hattiesburgh, MS 39402, 601–264–3856/

800–844–8378

Scientific Testing Laboratories, Inc., 463

Southlake Blvd., Richmond, VA 23236,

804–378–9130

Scott & White Drug Testing Laboratory, 600

S. 25th St., Temple, TX 76504, 800–749–

3788

S.E.D. Medical Laboratories, 500 Walter NE,

Suite 500, Albuquerque, NM 87102, 505–

244–8800, 800–999–LABS

Sierra Nevada Laboratories, Inc., 888 Willow

St., Reno, NV 89502, 800–648–5472

SmithKline Beecham Clinical Laboratories,

7600 Tyrone Ave., Van Nuys, CA 91045,

818–989–2520

SmithKline Beecham Clinical Laboratories,

801 East Dixie Ave., Leesburg, FL 34748,

904–787–9006 (formerly: Doctors &

Physicians Laboratory)

SmithKline Beecham Clinical Laboratories,

3175 Presidential Dr., Atlanta, GA 30340,

770–452–1590 (formerly: SmithKline BioScience Laboratories)

SmithKline Beecham Clinical Laboratories,

506 E. State Pkwy., Schaumburg, IL 60173,

708–885–2010 (formerly: International

Toxicology Laboratories),

SmithKline Beecham Clinical Laboratories,

400 Egypt Rd., Norristown, PA 19403, 800–

523–5447 (formerly: SmithKline BioScience Laboratories)

SmithKline Beecham Clinical Laboratories,

8000 Sovereign Row, Dallas, TX 75247,

214–638–1301 (formerly: SmithKline BioScience Laboratories)

SmithKline Beecham Clinical Laboratories,

1737 Airport Way South, Suite 200,

Seattle, WA 98134, 206–623–8100

South Bend Medical Foundation, Inc., 530 N.

Lafayette Blvd., South Bend, IN 46601,

219–234–4176

Southwest Laboratories, 2727 W. Baseline

Rd., Suite 6, Tempe, AZ 85283, 602–438–

8507

St. Anthony Hospital (Toxicology

Laboratory), P.O. Box 205, 1000 N. Lee St.,

Oklahoma City, OK 73102, 405–272–7052

Toxicology & Drug Monitoring Laboratory,

University of Missouri Hospital & Clinics,

2703 Clark Lane, Suite B, Lower Level,

Columbia, MO 65202, 314–882–1273

Toxicology Testing Service, Inc., 5426 N.W.

79th Ave., Miami, FL 33166, 305–593–

2260

TOXWORX Laboratories, Inc., 6160 Variel

Ave., Woodland Hills, CA 91367, 818–226–

4373 (formerly: Laboratory Specialists,

Inc.; Abused Drug Laboratories; MedTox

Bio-Analytical, a Division of MedTox

Laboratories, Inc.)

UNILAB, 18408 Oxnard St., Tarzana, CA

91356, 800–492–0800/818–343–8191

(formerly: MetWest-BPL Toxicology

Laboratory).

No laboratories withdrew from the

National Laboratory Certification

Program in May.

Richard Kopanda,

Executive Officer, Substance Abuse and

Mental Health Services Administration.

[FR Doc. 96–13875 Filed 6–3–96; 8:45 am]

BILLING CODE 4160–20–P

Pursuant to Public Law 92–463, Notice

Is Hereby Given of the Meeting of the

Substance Abuse and Mental Health

Services Administration (SAMHSA)

National Advisory Council in June

1996

A portion of the meeting of the

SAMHSA National Advisory Council

will be open and will include

discussions concerning issues on

SAMHSA’s appropriation and budget,

reorganization, and Knowledge

Development and Application Program.

These will also be a legislative update,

an update on the Agency’s managed

care activities, and a discussion on

issues of quality in a managed care

environment. In addition, there will be

a report on an exemplary substance

abuse prevention grantee, and status

reports by the Council’s workgroups on

Public Education, and Children’s, and